Latest Pfizer News

Study Backs RSV Vaccine Safety During Pregnancy
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit public health
Masks work, our comprehensive review has found
Caroline Ran Receives Research Grant in Migraine Studies
Too many Australians aren’t getting a flu vaccine. Why, and what can we do about it?
New sickle cell disease drug approved for use in England – here’s how voxelotor works
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation
We looked at genetic clues to depression in more than 14,000 people. What we found may surprise you
Migraine sufferers in England may soon be able to access preventative drug – here’s how atogepant works
Three quarters of Australians at higher risk of serious illness from COVID-19 do not have a COVID plan with their GP
Constitutional complaint brought against Federal Court Judge for concealing pharma connections
Cell & Gene Catalyst submits feedback on HTA consultation
Study Shows How Oestrogen Protects Against Fatty Liver
New Monitoring Tool Is Making Vaccine Rollouts Safer
Jane Morgan and Brian Leedman Appointed to the Board of Directors of BlinkLab – Early and Accurate Detection of Autism using an…
An RSV vaccine has been approved for people over 60. But what about young children?
Space travel taxes astronauts’ brains. But microbes on the menu could help in unexpected ways
Discovery of drug candidate to potentially tackle ER-positive breast cancer
One-third of Australians do not believe COVID-safe measures are important ahead of the holiday season
New COVID vaccine in pharmacies from today
XELJANZ® (tofacitinib citrate) PBS-listed for patients aged 2 years and older with active polyarticular course juvenile idiopathic arthritis (pcJIA)
BioNTech to establish clinical-scale mRNA manufacturing facility at La Trobe University
Australia’s Cell and Gene Catalyst calls for Expressions of Interest
Could antivirals reduce your risk of long COVID? Where the research is up to on prevention and treatment
New Covid vaccines available to target current variants
ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines
Medical manufacturing boost to create local jobs
Director appointed to Australia’s Cell and Gene Catalyst
Alexion completes purchase and licence agreement for early-stage rare disease gene therapy portfolio from Pfizer
TGA Product Information safety updates 13 September
Covid vaccine safety report – 24-08-2023
Covid vaccine safety report – 10-08-2023
New AusBiotech report shows increasing US investment in Australian biotechs
Iraq eliminates trachoma as a public health problem
Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies
AstraZeneca appoints Sharon Barr as Executive Vice President BioPharmaceuticals R&D
Unapproved GMOs in Pfizer and Moderna mRNA Covid-19 vaccines, court case alleges
Covid vaccine safety report – 27-07-2023
RSV is everywhere right now. What parents need to know about respiratory syncytial virus
TGA Product Information safety updates 24 July
Pfizer’s COVID-19 oral anti-viral available to more Australians on the Pharmaceutical Benefits Scheme from 1 July
Covid vaccine safety report – 29-06-2023
‘The dirty disease’ – both smokers and non-smokers get lung cancer. They face stigma on top of illness
TGA Product Information safety updates 23 June
Covid vaccine safety report – 15-06-2023
Australians believe COVID-19 risk is ‘new normal’, yet with winter here, COVID-safe behaviours are in decline
Vaxxas appoints former Pfizer executive as chief medical officer
Product Information safety updates – April and May 2023